Professor Jemima Mellerio

Consultant Dermatologist

Skin Health & Allergy

Sub-specialties: Adult Dermatology, Paediatric Dermatology, Sun Damage, Skin Cancer, Dermatology, Mole Checks, Moles, Acne, Eczema, Birthmarks, Epidermolysis Bullosa, Pigmentation Disorders, Ichthyosis, Keratoderma.

Overview

bookings.skinhealthallergy@onewelbeck.com

02036532007

Overview

Prof Mellerio treats a range of dermatology issues including skin problems, birthmarks and hair disorders, as well treating sun damage and skin cancers. Additionally, she is an international expert in the diagnosis and treatment of genetic skin diseases including ichthyosis, epidermolysis bullosa, ectodermal dysplasia and other related disorders.

About Professor Jemima Mellerio

Professor Jemima Mellerio is an experienced consultant in all areas of general adult and paediatric dermatology. Her NHS work is at St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust.

Prof Mellerio treats a range of dermatology issues including skin problemsbirthmarks and hair disorders, as well as treating sun damage and skin cancers. Additionally, she is an international expert in the diagnosis and treatment of genetic skin diseases including ichthyosis, epidermolysis bullosa, ectodermal dysplasia and other related disorders. She also holds an honorary chair of paediatric dermatology at King’s College London.

Prof Mellerio is on the executive committees of the British Association of Dermatologists, the British Society of Paediatric and Adolescent Dermatology, and the International Society of Pediatric Dermatology. She is also a Fellow of the Royal College of Physicians. She was formerly the Chief of Dermatology at St John’s and has also been the President of the Section of Dermatology of the Royal Society of Medicine.

Prof Mellerio lectures both nationally and internationally in her speciality and has over 200 peer-reviewed publications as well as having authored many chapters in prominent textbooks of dermatology. Research interests include epidermolysis bullosa and other genodermatoses, as well as other aspects of general adult and paediatric dermatology.

Professor Jemima Mellerio gained a first class BSc in Physiology at the London Hospital Medical College and undertook her specialist dermatology training at St John’s Institute of Dermatology and King’s College Hospital, joining the Specialist Register for Dermatology in 2002.

In 2003, she was the dermatologist for the Paediatric EB Service at Great Ormond Street Hospital for Children NHS Foundation Trust for 14 years. After completing her MD thesis in Genotype-Phenotype Correlation in EB Professor Mellerio has continued to work on gene discovery for novel forms of EB and promotes holistic multidisciplinary care for paediatric and adult skin disorders, rare disease clinical trials, teaching and training.

Areas of Expertise

Prof Jemima Mellerio performs a range of treatments including:

Some of the conditions she commonly treats are:

Additional Information

Qualifications

  • BSc Physiology 1988
  • MB BS (London) 1991
  • MRCP (UK) 1994
  • MD 2000
  • FRCP (UK) 2007

Awards

  • Chief of Dermatology, St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospital September 2018 to date
  • Lead, Adult Epidermolysis Bullosa Service, Guy’s and St Thomas’ Hospital 2003 to date
  • Lead, Paediatric and Genetic Dermatology, Guy’s and St Thomas’ Hospital 2006-2018
  • President, Dermatology Section, Royal Society of Medicine 2018-2019
  • Co-chair European Reference Network-Skin Epidermolysis Bullosa Group 2016-2020
  • Member Executive committee British Society of Paediatric Dermatology 2014 to date
  • British Association of Dermatologists South London Representative and Executive Committee Member 2023 to date

Memberships

  • British Association of Dermatologists
  • British Society for Paediatric Dermatology
  • British Society for Investigative Dermatology
  • European Society for Pediatric Dermatology
  • European Association of Dermatovenereology
  • International Society for Pediatric Dermatology
  • European Dermatology Forum
  • European Society for Dermatological Research
  • Royal Society of Medicine, Section of Dermatology

Research Highlights

Prof Jemima Mellerio has authored over 150 peer-reviewed publications including:

Key Publications

  • Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study. Mellerio JE, Pillay EI, Ledwaba-Chapman L, Bisquera A, Robertson SJ, Papanikolaou M, McGrath JA, Wang Y, Martinez AE, Jeffs E. Orphanet J Rare Dis. 2023; 18: 235.
  • Costs of community care for individuals with recessive dystrophic epidermolysis bullosa: findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study. Jeffs E, Pillay E, Ledwaba-Chapman L, Bisquera A, Robertson S, McGrath J, Wang Y, Martinez A, Patel A, Mellerio J. Skin Health Dis. 2023: e314.
  • Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES). Jeffs E, Pillay EI, Ledwaba-Chapman L, Bisquera A, Robertson SJ, McGrath JA, Wang Y, Martinez AE, Mellerio JE. Orphanet J Rare Dis. 2024; 19: 375.
  • Epidermolysis bullosa. Bardhan A, Bruckner-Tuderman L, Chapple ILC, Fine JD, Harper N, Has C, Magin TM, Marinkovich MP, Marshall JF, McGrath JA, Mellerio JE, Polson R, Heagerty AH. Nat Rev Dis Primers. 2020; 6: 78.
  • Consensus re-classification of inherited epidermolysis bullosa and other disorders with skin fragility. Has C, Bauer JW, Bodemer C, Bolling M, Bruckner-Tuderman L, Diem A, Fine JD, Heagerty A, Hovnanian A, Marinkovich P, Martinez AE, McGrath JA, Moss C, Murrell DF, Palisson F, Schwieger-Briel A, Sprecher E, Tamai K, Uitto J, Woodley DT, Zambruno G, Mellerio JE. Br J Dermatol. 2020; 183: 614-27. https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjd.18921
  • Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa – best clinical practice guidelines. Mellerio JE, Robertson SJ, Bernardis C, Diem A, Fine JD, George R, Goldberg D, Halmos GB, Harries M, Jonkman MF, Lucky A, Martinez AE, Maubec E, Morris S, Murrell DF, Palisson F, Pillay EI, Robson A, Salas-Alanis JC, McGrath JA. Br J Dermatol 2016; 174: 56-67.
    https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjd.14104
  • Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa. Rashidghamat E, Kadiyirire T, Ayis S, Petrof G, Liu L, Pullabhatla V, Ainali C, Guy A, Aristodemou S, McMillan JR, Ozoemena L, Mee J, Prmanik R, Saxena A, Nuamah R, de Rinaldis E, Serrano S, Maurin C, Martinez-Queipo M, Lwin SM, Ilic D, Martinez A, Dazzi F, Slaper-Cortenbach I, Westinga K, Zeddies S, van den Broek M, Onoufriadis A, Mellerio JE, McGrath JA. J Am Acad Dermatol. 2020; 83: 447-54.
    https://www.jaad.org/action/showPdf?pii=S0190-9622%2819%2933130-5

Major insurers served

If your insurer is not listed, please contact us to confirm your coverage. Please note this does not guarantee coverage or fee assurance. Patients should confirm with their insurer to ensure coverage, check if the doctor is fee-assured, or verify if their policy includes the doctor in question.